logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

On October 16th, IH Retail (01373) spent HKD 120,000 to repurchase 150,000 shares.

date
17:54 20/10/2025
avatar
GMT Eight
International home retail (01373) announced that on October 16, 2025, the company invested 120,000 Hong Kong dollars...
IH RETAIL (01373) announced that on October 16, 2025, the company will spend 120,000 Hong Kong dollars to repurchase 150,000 shares.
Related Articles
HK Stock
SUNART RETAIL (06808) issues profit warning, expecting a mid-term shareholders' loss of approximately RMB 140 million.
US Stock
Alphabet's (GOOGL.US) self-driving department Waymo is being investigated by the NHTSA for allegedly violating rules regarding stopping for school buses.
US Stock
Roche (RHHBY.US) has been approved to use "Ocrelizumab" to treat lupus nephritis.
SUNART RETAIL (06808) issues profit warning, expecting a mid-term shareholders' loss of approximately RMB 140 million.
HK Stock
Alphabet's (GOOGL.US) self-driving department Waymo is being investigated by the NHTSA for allegedly violating rules regarding stopping for school buses.
US Stock
Roche (RHHBY.US) has been approved to use "Ocrelizumab" to treat lupus nephritis.
US Stock
RECOMMEND
Why European Automakers Are Opposing Dutch Sanctions
Why European Automakers Are Opposing Dutch Sanctions
icon
20/10/2025
Domestic Commercial Rockets Enter Batch Launch Era: Behind the Scenes a Sixfold Cost Gap and Reusability as the Key Breakthrough
Domestic Commercial Rockets Enter Batch Launch Era: Behind the Scenes a Sixfold Cost Gap and Reusability as the Key Breakthrough
icon
20/10/2025
Multiple Positive Catalysts Lift Tech Stocks; UBS Elevates China Tech to Most Attractive, Citing AI as Core Rationale
Multiple Positive Catalysts Lift Tech Stocks; UBS Elevates China Tech to Most Attractive, Citing AI as Core Rationale
icon
20/10/2025
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.